Trade Mark Journal No.2026/010 6 March 2026

UK00004340356 13 February 2026 (5)

IGLANBA

Class 5: Pharmaceuticals; pharmaceutical preparations; pharmaceutical products; insulin; insulin glargine; insulin analog; anti-diabetics; pharmaceuticals for treating diabetes; pharmaceutical preparations for treating diabetes; pharmaceutical products for treating diabetes; pharmaceutical preparations, namely, injectable insulin; pharmaceutical preparations, namely, injectable insulin glargine; pharmaceutical preparations, namely, injectable insulin analog; pharmaceutical preparations, namely, injectable anti-diabetics; injectable pharmaceutical preparations for treating diabetes; injectable pharmaceutical products for treating diabetes; injectors sold filled with insulin; insulin injectors sold filled with insulin glargine; insulin injectors sold filled with insulin analog; injectors sold filled with pharmaceuticals for treating diabetes; injectors sold filled with anti-diabetics.

Emerge Bioscience Pte. Ltd.

Representative: Bryers Intellectual Property Ltd